CIK: 1238250 - Address: C/O Ampio Pharmaceuticals, Inc., 373 Inverness Parkway, Suite 200, Englewood, CO 80112
15 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret117-1-4-9-1010161
S%wins86868686292967

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/26/23 13:30
5/24/23
AMPEAmpio Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsMartino Michael ACODOCEOP220.2877077New77D
7/8/10 12:06
7/6/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWAHFormer DM.d197.25133011D146-39-40-38-16-8-6-31118132932
7/8/10 12:06
7/6/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWAHFormer DS.d-3313.021-3-1911D146-39-40-38-16-8-6-31118132932
6/23/10 17:17
6/21/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADM.dm147.25122111D152-34-53-33-28-3-20-1-3-14-131425
6/23/10 17:17
6/21/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADS.dm00.001-2-1511D152-34-53-33-28-3-20-1-3-14-131425
6/21/10 13:56
6/17/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADM.d347.12157811D151-40-53-29-27-7200-2-14-151517
6/21/10 13:56
6/17/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADS.d00.001-5-3111D151-40-53-29-27-7200-2-14-151517
6/15/10 18:15
6/11/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADM.dm376.661610311D136-47-55-36-37-10-32-1-1-8-91431
6/15/10 18:15
6/11/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADS.dm00.001-6-3411D136-47-55-36-37-10-32-1-1-8-91431
6/7/10 13:47
6/3/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADM.d473.3611411D140-43-57-15-36-24-7-1-10-9-81227
6/7/10 13:47
6/3/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADS.d-20214.461-14-5611D140-43-57-15-36-24-7-1-10-9-81227
5/20/10 18:41
5/18/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADM.d106.66121611D18929-45-1-18-20-10-9-1-10-15-16-4-6
5/20/10 18:41
5/18/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADS.d-2718.181-2-1211D18929-45-1-18-20-10-9-1-10-15-16-4-6
5/18/10 19:28
5/13/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADM.dm876.6611311D211125-398-13-11-13-6-2-10-18-20-7-11
5/18/10 19:28
5/13/10
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartino Michael AWADS.dm-24418.671-13-5411D211125-398-13-11-13-6-2-10-18-20-7-11

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact